NCT00224575

Brief Summary

Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment. in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
260

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2004

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2004

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2005

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 23, 2005

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2005

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2006

Completed
Last Updated

March 8, 2016

Status Verified

March 1, 2016

Enrollment Period

1 year

First QC Date

September 13, 2005

Last Update Submit

March 7, 2016

Conditions

Myocardial Ischemia

Keywords

Veterans

Outcome Measures

Primary Outcomes (1)

  • therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly

    during hospitalization

Secondary Outcomes (1)

  • part link, in the treatment modification, with diagnosis reassessment and the part link with treatment optimization, death and rehospitalization in the subsequent 6 and 12 months

    during hospitalization

Study Arms (1)

1

EXPERIMENTAL

Diagnosis strategy and subsequent therapeutic reassessment All patients are in that arms. They all receive the diagnosis reassessment strategy.

Other: diagnosis reassessmentOther: Diagnosis strategy and subsequent therapeutic reassessment

Interventions

diagnosis reassessmentOTHER

Strategy of diagnosis reassessment following a decision tree.

Also known as: no other names to specified
1
Diagnosis strategy and subsequent therapeutic reassessmentOTHER

Performed by geriatricians, following a decision tree, based on medical history, electrocardiogram, cardiac echotomography and stress scintigraphy

1

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • patients 75 of age or older hospitalized in a geriatric service and suspect of coronary heart disease

You may not qualify if:

  • acute myocardial infarction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Bichat

Paris, Paris, 75018, France

Location

MeSH Terms

Conditions

Myocardial Ischemia

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • legrain sylvie

    APHP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 23, 2005

Study Start

November 1, 2004

Primary Completion

November 1, 2005

Study Completion

November 1, 2006

Last Updated

March 8, 2016

Record last verified: 2016-03

Locations

FR(1)